sparkling
The Pax5 gene, coding for the transcription factor BSAP, was mutated in the mouse germline by
targeted disruption. Homozygous mutant mice are born alive, became growth retarded, and usually
die within three weeks. About 5% of mutants survive to adulthood and are fertile, but severely
runted. Morphogenesis of the posterior midbrain is affected as early as embryonic day 16.5, leading
to a reduction of the inferior colliculus near the midline and to altered foliation of the anterior
cerebellum. All mutants fail to produce small pre-B, B, and plasma cells, owing to a complete arrest of B cell development at an early precursor stage. These data define a key role for Pax5 in early B lymphopoiesis and midbrain patterning (Urbanek, 1994).
Pax-5 codes for the transcription factor BSAP, which plays an important role in midbrain patterning, B cell development, and lymphoma formation. Pax-5 is known to control gene expression by recognizing its target genes via the NH2-terminal paired domain and by regulating transcription through a COOH-terminal regulatory module consisting of activating and inhibitory sequences. The central region of Pax-5 contains a sequence with significant homology to the first alpha-helix of the paired-type homeodomain. This partial homeodomain has been highly conserved throughout vertebrate evolution because it is found not only in Pax-5 but also in the related Pax-2 and Pax-8 members of the same Pax subfamily. The partial homeodomain binds the TATA-binding protein (TBP) and retinoblastoma (Rb) gene product. Both TBP and Rb were shown by coimmunoprecipitation experiments to directly associate with Pax-5 in vivo. The conserved core domain of TBP and the pocket region as well as COOH-terminal sequences of Rb are required for interaction with the partial homeodomain of Pax-5 in in vitro binding assays. Furthermore, Pax-5 is specifically bound only by the underphosphorylated form of Rb. These data indicate that Pax-5 is able to contact the basal transcription machinery through the TBP-containing initiation factor TFIID, and that its activity can be controlled by the cell cycle-regulated association with Rb (Eberhard, 1999).
Pax and homeodomain transcription factors are essential
for the formation of an organizing center at the midbrain-hindbrain
boundary (mhb), which controls the genesis of
the midbrain and cerebellum in the vertebrate embryo.
Pax2 and Pax5 are sequentially activated in this brain
region, with Pax2 expression preceding that of Pax5. Using
a transgenic reporter assay, a
conserved 435 bp enhancer has been identified in the 5' flanking region of
mammalian Pax5 genes that directs lacZ expression in the
correct temporal and spatial pattern at the mhb. This
minimal enhancer is composed of two distinct elements, as
shown by protein-binding assays with mhb-specific
extracts. The proximal element contains overlapping
consensus binding sites for members of the Pax2/5/8 and
POU protein families, whereas a distal element is bound
by homeodomain and zinc finger transcription factors.
Expression analysis of transgenes carrying specific
mutations in these recognition motifs has identified the Pax- and
homeodomain-binding sites as functional elements
that cooperatively control the activity of the mhb
enhancer. lacZ genes under the control of either the
minimal enhancer or the endogenous Pax5 locus are
normally expressed at the mhb in Pax5 mutant embryos,
indicating that this enhancer does not depend on
autoregulation by Pax5. However, in Pax2 mutant embryos,
expression of the endogenous Pax5 gene is
delayed and severely reduced in lateral aspects of the
neural plate, which upon neural tube closure, becomes the
dorsal mhb region. This cross-regulation by Pax2 is
mediated by the Pax-binding site of the minimal enhancer:
upon specific mutation, this results in severely reduced
transgene expression in the dorsal part of the mhb.
Together these data indicate that Pax2 and homeodomain
proteins directly bind to and cooperatively regulate the
mhb enhancer of Pax5 (Pfeffer, 2000).
Fgf8, which is expressed at the embryonic mid/hindbrain
junction, is required for and sufficient to induce the
formation of midbrain and cerebellar structures. To
address the genetic pathways through which FGF8 acts, the epistatic relationships of mid/hindbrain
genes that respond to FGF8 were examined, using a novel mouse brain
explant culture system. En2 and Gbx2 are
the first genes to be induced by FGF8 in wild-type E9.5
diencephalic and midbrain explants treated with FGF8-soaked beads. By examining gene expression in En1/2
double mutant mouse embryos, it was found that Fgf8, Wnt1
and Pax5 do not require the En genes for initiation of
expression, but do for their maintenance, and Pax6
expression is expanded caudally into the midbrain in
the absence of EN function. Since E9.5 En1/2 double
mutants lack the mid/hindbrain region, forebrain mutant
explants were treated with FGF8 and, significantly, the EN
transcription factors were found to be required for
induction of Pax5. Thus, FGF8-regulated expression of
Pax5 is dependent on EN proteins, and a factor other than
FGF8 could be involved in initiating normal Pax5
expression in the mesencephalon/metencephalon. The En
genes also play an important, but not absolute, role
in repression of Pax6 in forebrain explants by FGF8.
Gbx2 gain-of-function studies have shown that
misexpression of Gbx2 in the midbrain can lead to
repression of Otx2. However, in the absence of Gbx2, FGF8
can nevertheless repress Otx2 expression in midbrain
explants. In contrast, Wnt1 is initially broadly induced in
Gbx2 mutant explants, as in wild-type explants, but not
subsequently repressed in cells near FGF8 that normally
express Gbx2. Thus GBX2 acts upstream of, or parallel to,
FGF8 in repressing Otx2, and acts downstream of FGF8 in
repression of Wnt1. This is the first such epistatic study
performed in mouse that combines gain-of-function and
loss-of-function approaches to reveal aspects of mouse gene
regulation in the mesencephalon/metencephalon that have
been difficult to address using either approach alone (Liu, 2001).
The transcription factor Pax-5 is expressed during the early stages of B-cell
differentiation and influences the expression of several B-cell-specific genes. In
addition to the existing isoform (Pax-5, which has been renamed Pax-5a), three new isoforms, Pax-5b, Pax-5d, and Pax-5e, have been isolated from murine spleen and
B-lymphoid cell lines using library screenings and polymerase chain reaction
amplification. Isoforms Pax-5b and Pax-5e have their second exon spliced out,
resulting in proteins with only a partial DNA-binding domain. Isoforms Pax-5d and
Pax-5e have deleted the 3'-region, which encodes the transactivating domain, and
replaced it with a novel sequence. Pax-5a and Pax-5b proteins
have been detected using Western blot analysis. Pax-5a is detectable in pro-, pre-, and
mature B-cell lines, but not in two plasmacytomas; Pax-5b is present at
low levels in mature B-cell lines and, unexpectedly, in one plasma cell line, but not in
pro-B-cell or T-cell lines. In vitro translated Pax-5a
and Pax-5d, but not Pax-5b or Pax-5e, can interact with a B-cell-specific activator
protein-binding site on the blk promoter. Pax-5d
is present in nuclear extracts of some (but not all) B-lymphoid lines and interacts
with the B-cell-specific activator protein-binding site. The pattern of differential
expression of alternatively spliced Pax-5 isoforms suggests that they may be important
regulators of transcription during B-cell maturation (Zwollo, 1997)
The Pax5 gene coding for the transcription factor BSAP has an essential role in B lymphopoiesis and
midbrain development. A detailed analysis of the B-cell phenotype of Pax5 mutant
mice is presented that reveals a differential dependency of fetal and adult B lymphopoiesis on this transcriptional
regulator. B-cell development is arrested in the bone marrow at the early pro-B (pre-BI) cell stage,
which is characterized by expression of the early markers c-kit, CD43, lambda5, VpreB, and HSA and
the absence of later markers CD25 and BP-1. These pre-BI cells fail to express the BSAP target
gene CD19 and are capable of long-term proliferation in vitro in the presence of stromal cells and IL-7.
B-lymphoid progenitors can not be detected in the fetal liver of Pax5 mutant embryos. However,
Pax5-deficient fetal liver cells give rise to the development of pre-BI cells in bone marrow on
transplantation into lethally irradiated mice. These data indicate different functions of Pax5 in the
distinctive microenvironments of fetal liver and adult bone marrow. As shown by PCR analyses, the
pre-BI cells in Pax5-deficient bone marrow undergo D(H)-to-J(H) rearrangement of the
immunoglobulin heavy-chain locus at normal frequency. In contrast, V(H)-to-D(H)J(H)
rearrangements are reduced approximately 50-fold in Pax5-deficient pre-BI cells, suggesting a role
for Pax5 in the developmental pathway controlling V-to-DJ recombination (Nutt, 1997).
The paired box transcription factor Pax-5 (B-cell-specific activator protein) is a key
regulator of lineage-specific gene expression and differentiation in B-lymphocytes. Pax-5 functions as a cell type-specific docking protein that facilitates
binding of the early B-cell-specific mb-1 promoter by proteins of the Ets
proto-oncogene family. Transcriptional activity of the mb-1 promoter in pre-B-cells is
critically dependent on binding sites for Pax-5:Ets complexes. Ternary complex
assembly requires only the Pax-5 paired box and ETS DNA-binding domains.
Mutation of a single base pair in the ternary complex binding site allows for
independent binding by Ets proteins but, conversely, inhibits the binding of Pax-5 by
itself. Strikingly, the mutation reverses the pattern of complex assembly: Ets proteins
recruit Pax-5 to bind the mutated sequence. Recruitment of Net and Elk-1 (but not
SAP1a) by Pax-5 defines a functional difference between closely related Ets proteins.
Replacement of a valine (V68) in the ETS domain of SAP1a by aspartic acid (as
found in c-Ets-1, Elk-1, and Net) enhances ternary complex formation by more than
60-fold. Together, these observations define novel transcription factor interactions that
regulate gene expression in B cells (Fitzsimmons, 1996).
During B cell differentiation, the pre-B cell stage plays a significant role in
immunoglobulin gene rearrangement in the context of the allelic exclusion and kappa
chain gene rearrangement. The early B cell-specific
binding protein (EBB)-1 transcription factor binds to the promoters of two pre-B
cell-specific genes, VpreB and lambda5, and regulates their pre-B cell-specific
expression. EBB-1 binds to the KI and KII sites in the
upstream area of Jkappa region, which are crucial for kappa chain gene rearrangement.
Gene transfer and gel-shift assays demonstrate that EBB-1 is identical to Pax-5 and
binds to promoters of VpreB and lambda5 as well as the KI and KII sites. These results
suggest that Pax-5 plays an important role in the coordinate regulation of several
immunoglobulin gene family members that are crucial in B cell development (Tian, 1997).
Cytokine regulation of B cell development was analyzed using interleukin-2 (IL-2)-induced transcription
of the J chain gene as a model system. A nuclear target of the IL-2 signal is identified as the Pax5
transcription factor, BSAP, which recognizes a negative regulatory motif in the J chain promoter.
Functional assays show that BSAP mediates the silencing of the J chain gene during the early stages
of B cell development, but repression is relieved during the antigen-driven stages in a
concentration-dependent manner by an IL-2-induced down-regulation of BSAP RNA expression. At
the low levels present in J chain-expressing plasma cells, BSAP repression can be overridden by
positive-acting factors binding to down-stream J chain promoter elements. Overexpression of BSAP in
these cells reverses the positive regulation and inhibits J chain gene transcription. Thus, IL-2
regulation of BSAP concentration may provide a mechanism for controlling both repressor and
activator functions of BSAP during a B cell immune response (Rinkenberger, 1996).
The Pax5 transcription factor BSAP (B-cell-specific activator protein) is known to bind to and repress
the activity of the immunoglobulin heavy chain 3' alpha enhancer. An
element, designated alpha P, lies approximately 50 bp downstream of the BSAP binding site 1 and
is required for maximal enhancer activity. In vitro binding experiments suggest that the 40-kDa protein
that binds to this element (NF-alpha P) is a member of the Ets family present in both B-cell and
plasma-cell nuclei. However, in vivo footprint analysis suggests that the alpha P site is occupied only in
plasma cells, whereas the BSAP site is occupied in B cells but not in plasma cells. When Pax5 binding
to the enhancer in B cells is blocked in vivo by transfection with a triple-helix-forming oligonucleotide,
an alpha P footprint appears and endogenous immunoglobulin heavy chain transcripts increase. The
triple-helix-forming oligonucleotide also increases enhancer activity of a transfected construct in B
cells, but only when the alpha P site is intact. Pax5 thus regulates the 3' alpha enhancer and
immunoglobulin gene transcription by blocking activation by NF-alpha P (Neurath, 1995).
Recent studies have elucidated cell-lineage-specific three-dimensional genome organization; however, how such specific architecture is established or maintained is unclear. This study hypothesized that lineage-defining transcription factors maintain cell identity via global control of genome organization. These factors bind many genomic sites outside of the genes that they directly regulate and thus are potentially implicated in three-dimensional genome organization. Using chromosome-conformation-capture techniques, this study showed that the transcription factor Paired box 5 (Pax5) is critical for the establishment and maintenance of the global lineage-specific architecture of B cells. Pax5 was found to supervise genome architecture throughout B cell differentiation, until the plasmablast stage, in which Pax5 is naturally silenced and B cell-specific genome structure is lost. Crucially, Pax5 did not rely on ongoing transcription to organize the genome. These results implicate sequence-specific DNA-binding proteins in global genome organization to establish and maintain lineage fidelity (Johanson, 2018).
The t(9;14)(p13;q32) translocation is associated with approximately 50% of
lymphoplasmacytoid lymphoma (LPL), a subtype of B-cell non-Hodgkin's lymphoma
(NHL). The chromosomal breakpoint involves a junction between 9p13 and the switch micro region of
the Ig heavy chain locus (IgH) on 14q32. The 9p13 breakpoint in one case maps within a
270-kb restriction fragment containing breakpoints
associated with an alpha-heavy chain disease case (MAL) and KI-1 positive diffuse
large cell lymphoma (DLCL) cell line (KIS-1). The same fragment also contains the
PAX-5 gene, which encodes a B-cell specific transcription factor involved in the
control of B-cell proliferation and differentiation. The breakpoints
map within the 5' noncoding region of PAX-5, while the 9p13 breakpoint of
MAL maps 230 to 270 kb upstream of PAX-5. In all three cases, the translocation
causes the juxtaposition of the PAX-5 gene to the IgH locus in the opposite direction
of transcription. Cell lines containing the translocation show an 11-fold overexpression of PAX-5
mRNA and a significantly reduced expression of the p53 gene, which is normally
regulated by PAX-5. These findings suggest that the PAX-5 gene is the target of the t(9;14)
in LPL whereby its expression may be deregulated by juxtaposition to IgH regulatory
elements, thus contributing to lymphomagenesis (Iida, 1996).
Analyses of the human PAX-5 locus and of the 5' region of the mouse Pax-5 gene
reveal that transcription from two distinct promoters results in splicing of two
alternative 5' exons to the common coding sequences of exons 2-10. Transcription
from the upstream promoter initiates downstream of a TATA box and occurs
predominantly in B-lymphocytes, whereas the TATA-less downstream promoter is
active in all Pax-5-expressing tissues. The human PAX-5 gene is located on
chromosome 9 in region p13, which is involved in t(9;14)(pl3;q32) translocations
recurring in small lymphocytic lymphomas of the plasmacytoid subtype and in derived
large-cell lymphomas. A t(9;14) breakpoint justaposes the immunoglobulin
heavy-chain (IgH) locus on 14q32 to chromosome 9p13. The translocation
breakpoint is located 1807 base pairs upstream of exon 1A of PAX-5, thus bringing
the potent Emu enhancer of the IgH gene into close proximity to the PAX-5
promoters. These data suggest that deregulation of PAX-5 gene transcription by the
t(9;14)(pl3;q32) translocation contributes to the pathogenesis of small lymphocytic
lymphomas with plasmacytoid differentiation (Busslinger, 1996).
Medulloblastoma is a pediatric brain tumor originating in the human cerebellum. A collection of 23
medulloblastomas was analyzed for expression of the developmental control genes of the PAX and EN
gene families. Of all nine PAX genes investigated, only
PAX5 and PAX6 (Drosophila homolog: Eyeless) are consistently expressed in most medulloblastomas (70 and 78% of all cases,
respectively), as are the genes EN1 (57%) and EN2 (78%) (See Drosophila Engrailed). EN1, EN2, and PAX6 genes are also
expressed in normal cerebellar tissue, and their expression in medulloblastoma is consistent with the
hypothesis that this tumor originates in the external granular layer of the developing cerebellum. PAX5
transcripts are, however, not detected in the neonatal cerebellum, indicating that this gene is
deregulated in medulloblastoma. In the desmoplastic variant of medulloblastoma, PAX5 expression is
restricted to the reticulin-producing proliferating tumor areas containing undifferentiated cells; PAX5
is not expressed in the reticulin-free nonproliferating islands undergoing neuronal differentiation.
These data suggest that deregulated expression of PAX5 correlates positively with cell proliferation
and inversely with neuronal differentiation in desmoplastic medulloblastoma (Kozmik, 1995).
Pax8 gene structure and alternative splicing
Evolutionary homologs continued: part 5/5 | back to part 1/5 | part 2/5 | part 3/5
Home page: The Interactive Fly © 1995, 1996 Thomas B. Brody, Ph.D.
The Interactive Fly resides on the
sparkling:
Biological Overview
| Regulation
| Developmental Biology
| Effects of Mutation
| References
Society for Developmental Biology's Web server.